Target intelligence / Profile preview

YWHAQ pseudogene 5 (YWHAQP5)

Target: YWHAQP5
Molecular classification: Other (Pseudogene)

Overview

YWHAQP5 encodes a pseudogene homologous to YWHAQ (14-3-3 protein theta). Pseudogenes are genomic DNA sequences similar to known genes but generally do not encode a functional product. YWHAQP5 does not produce a protein, nor is it involved in known cellular signaling or disease roles, and therefore is not considered a therapeutic target[3][7]. If you intended to ask about the functional YWHAQ gene (14-3-3 protein theta), refer to the entries for YWHAQ, which are associated with signal transduction, apoptosis, and neurological disease (such as amyotrophic lateral sclerosis)[1][2]. The pseudogene YWHAQP5, however, is not a valid drug target and contains no known biological or therapeutic relevance.

Other names: YWHAQP5YWHAQ pseudogene 5

Beyond the preview

Go deeper on YWHAQ pseudogene 5 (YWHAQP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YWHAQ pseudogene 5 (YWHAQP5).

Explore the full profile